Epidemiology


Etiology


Caused by superantigen toxins from Staphylococcus aureus (TSST-1) or Streptococcus pyogenes (SpeA, SpeC).

  • Staphylococcal TSS:
    • Source: Often associated with tampon use, nasal packing, or post-surgical wounds.
    • Bacteremia: Usually negative; it’s a localized infection with systemic toxin effects.
  • Streptococcal TSS (STSS):
    • Source: Associated with an invasive infection, typically of the skin/soft tissue (e.g., necrotizing fasciitis, cellulitis).
    • Bacteremia: Frequently positive.
    • Prognosis: Higher mortality rate than staphylococcal TSS.

Pathophysiology


  • Superantigen production: Causative organisms (S. pyogenes and S. aureus) produce superantigens
  • Superantigen-mediated T-cell activation
    • Superantigens bypass processing and presentation by antigen-presenting cells.
    • Superantigens directly connect the MHC class II molecule on antigen-presenting cells to the T-cell receptor on T-cells by forming a bridge outside of the normal binding sites → nonspecific T-cell activation → rapid activation of excessive numbers of T cells → massive cytokine release
  • SIRS: ↑↑↑ Cytokines → generalized endothelial disruption → capillary leak syndrome → generalized edema → intravascular hypovolemia → organ dysfunction and disseminated intravascular coagulation (DIC)

Clinical features


Prodrome

  • Flu-like symptoms: high fever, chills, myalgia, headache, nausea, vomiting, diarrhea
  • Dermal rash: more common in menstrual staphylococcal TSS than in nonmenstrual staphylococcal TSS and streptococcal TSS
    • Transient erythematous macular (sunburn-like) rash
    • Commonly involves the palms and soles
    • Typically desquamates 1–2 weeks after onset.

Shock and end-organ dysfunction

  • Early: tachycardia, tachypnea, high fever, altered mental status
  • Late
    • Hypotension
    • Delayed capillary refill
    • Worsening altered mental status
    • Evidence of organ failure

Diagnostics


Treatment